What a year 2016 was for Infinera (NASDAQ:INFN) shareholders. The stock plunged over 50% last year, as its multiyear run of accelerating 20%-30% growth rates ground to a halt. The story changed from that of a high-growth technology company riding the secular trend of exploding data and bandwidth needs to one of stagnating revenues, profits turning to losses, increased competition, and end....More>>>
UBS analysts Colin Langan and Eddie Hsieh explain why they expect Tesla Motors’ (TSLA) “third-quarter good news to turn bad in the fourth quarter”:
JOHANNES EISELE/AFP/Getty Images
We see Tesla’s guidance for positive GAAP net income in Q4 as very challenging. ExcludingZero Emission Vehicle credits, Q3′s $0.71 profit would have been a $0.18 loss.....More>>>
Two presidents will move global markets this week.
First, the inauguration of President-elect Donald Trump on Friday, Jan. 20, has investors and markets anticipating what he will say when he speaks to the nation as U.S. president for the first time.
Historically, markets are always mixed leading up to and following a president’s inauguration. This year has been no different....More>>>
President-elect Donald J. Trump’s decision to pick Steven Mnuchin, a former Goldman Sachs partner, as the next Treasury Secretary is driving hopes on Wall Street that government sponsored mortgage giants Fannie Mae and Freddie Mac will be privatized in the new administration. “We’ve got to get them out of government control,” Mnuchin told Fox Business News on Wednesday morning....More>>>
Horizon Pharma (NASDAQ:HZNP) announced the acquisition of Raptor(NASDAQ:RPTP) for $9 per share or $800 million. Raptor was rumored to be an M&A target over the last few months and the price Horizon paid is right in the middle of my estimate range of $8 to $10 and at the high end of what I thought was a good price as a Horizon shareholder. The acquisition brings the EU infrastructure Horizon....More>>>